Literature DB >> 21658757

Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.

Pedro M Valencia1, Mikhail H Hanewich-Hollatz, Weiwei Gao, Fawziya Karim, Robert Langer, Rohit Karnik, Omid C Farokhzad.   

Abstract

The engineering of drug-encapsulated targeted nanoparticles (NPs) has the potential to revolutionize drug therapy. A major challenge for the smooth translation of targeted NPs to the clinic has been developing methods for the prediction and optimization of the NP surface composition, especially when targeting ligands (TL) of different chemical properties are involved in the NP self-assembly process. Here we investigated the self-assembly and properties of two different targeted NPs decorated with two widely used TLs that have different water solubilities, and developed methods to characterize and optimize NP surface composition. We synthesized two different biofunctional polymers composed of poly(lactide-co-glycolide)-b-polyethyleneglycol-RGD (PLGA-PEG-RGD, high water solubility TL) and PLGA-PEG-Folate (low water solubility TL). Targeted NPs with different ligand densities were prepared by mixing TL-conjugated polymers with non-conjugated PLGA-PEG at different ratios through nanoprecipitation. The NP surface composition was quantified and the results revealed two distinct nanoparticle assembly behaviors: for the case of PLGA-PEG-RGD, nearly all RGD molecules conjugated to the polymer were found to be on the surface of the NPs. In contrast, only ∼20% of the folate from PLGA-PEG-Folate was present on the NP surface while the rest remained presumably buried in the PLGA NP core due to hydrophobic interactions of PLGA and folate. Finally, in vitro phagocytosis and cell targeting of NPs were investigated, from which a window of NP formulations exhibiting minimum uptake by macrophages and maximum uptake by targeted cells was determined. These results underscore the impact that the ligand chemical properties have on the targeting capabilities of self-assembled targeted nanoparticles and provide an engineering strategy for improving their targeting specificity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658757      PMCID: PMC3146392          DOI: 10.1016/j.biomaterials.2011.04.078

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  33 in total

1.  Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment.

Authors:  Jie Pan; Yutao Liu; Si-Shen Feng
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

Review 2.  Impact of nanotechnology on drug delivery.

Authors:  Omid C Farokhzad; Robert Langer
Journal:  ACS Nano       Date:  2009-01-27       Impact factor: 15.881

Review 3.  Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

Authors:  Tewodros Mamo; E Ashley Moseman; Nagesh Kolishetti; Carolina Salvador-Morales; Jinjun Shi; Daniel R Kuritzkes; Robert Langer; Ulrich von Andrian; Omid C Farokhzad
Journal:  Nanomedicine (Lond)       Date:  2010-02       Impact factor: 5.307

Review 4.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

5.  Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Authors:  Fabienne Danhier; Nathalie Lecouturier; Benoît Vroman; Christine Jérôme; Jacqueline Marchand-Brynaert; Olivier Feron; Véronique Préat
Journal:  J Control Release       Date:  2008-10-09       Impact factor: 9.776

Review 6.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

Review 8.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

9.  Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.

Authors:  Yogesh B Patil; Udaya S Toti; Ayman Khdair; Linan Ma; Jayanth Panyam
Journal:  Biomaterials       Date:  2008-11-18       Impact factor: 12.479

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more
  37 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 2.  Perspectives on Dual Targeting Delivery Systems for Brain Tumors.

Authors:  Huile Gao
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-08       Impact factor: 4.147

Review 3.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

4.  Influenza A virus mimetic nanoparticles trigger selective cell uptake.

Authors:  Sara Maslanka Figueroa; Anika Veser; Kathrin Abstiens; Daniel Fleischmann; Sebastian Beck; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

5.  Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging.

Authors:  Aneta J Mieszawska; Anita Gianella; David P Cormode; Yiming Zhao; Andries Meijerink; Robert Langer; Omid C Farokhzad; Zahi A Fayad; Willem J M Mulder
Journal:  Chem Commun (Camb)       Date:  2012-05-03       Impact factor: 6.222

6.  Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.

Authors:  Pedro M Valencia; Eric M Pridgen; Minsoung Rhee; Robert Langer; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Nano       Date:  2013-11-11       Impact factor: 15.881

7.  Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles.

Authors:  Pedro M Valencia; Eric M Pridgen; Brian Perea; Suresh Gadde; Christopher Sweeney; Philip W Kantoff; Neil H Bander; Stephen J Lippard; Robert Langer; Rohit Karnik; Omid C Farokhzad
Journal:  Nanomedicine (Lond)       Date:  2012-10-17       Impact factor: 5.307

8.  The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles.

Authors:  Jing Wang; Michael Dzuricky; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2017-09-05       Impact factor: 11.189

Review 9.  Cell membrane-camouflaged nanoparticles for drug delivery.

Authors:  Brian T Luk; Liangfang Zhang
Journal:  J Control Release       Date:  2015-07-23       Impact factor: 9.776

10.  Spontaneous formation of heterogeneous patches on polymer-lipid core-shell particle surfaces during self-assembly.

Authors:  Carolina Salvador-Morales; Pedro M Valencia; Weiwei Gao; Rohit Karnik; Omid C Farokhzad
Journal:  Small       Date:  2012-10-26       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.